Article
In need of high-throughput behavioral systems.
Drug discovery today - 15 Sept 2002
Brunner Dani, Nestler Eric, Leahy Emer
Abstract excerpt
One of the current major bottlenecks in drug discovery is in vivo testing of candidate drugs in behavioral paradigms in normal or genetically altered mice. This testing is essential in discovering gene function and predicting potential efficacy of CNS drugs in humans. New efforts in the biotech community aim to alleviate this bottleneck by developing higher-throughput systems of behavioral, neurological and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
